Completion, Safety, and Efficacy of Tuberculosis Preventive Treatment Regimens Containing Rifampicin or Rifapentine
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Respiratory Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Completion, safety, and efficacy of tuberculosis preventive treatment regimens containing rifampicin or rifapentine: an individual patient data network meta-analysis
Lancet Respir Med 2023 Mar 23;[EPub Ahead of Print], N Winters, R Belknap, A Benedetti, A Borisov, JR Campbell, RE Chaisson, PC Chan, N Martinson, P Nahid, NA Scott, E Sizemore, TR Sterling, ME Villarino, JY Wang, D MenziesFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.